Avanos announces divestiture of hyaluronic acid product line to channel-markers medical

Alpharetta, ga. , july 31, 2025 /prnewswire/ -- avanos medical, inc. (nyse: avns), announced today the divestiture of its hyaluronic acid (ha) product line to channel-markers medical, llc (cmm), a privately held company based in raleigh, nc.
AVNS Ratings Summary
AVNS Quant Ranking